Patents Represented by Attorney Louis J. Wille
  • Patent number: 6037353
    Abstract: The present invention relates to a method of providing an antihistaminic effect in a hepatically impaired patient in need thereof comprising administering to said patient an effective antihistaminic amount of a compound of the formula ##STR1## wherein R.sub.1 is hydrogen or hydroxy;R.sub.2 is hydrogen;or R.sub.1 and R.sub.2 taken together form a second bond between the carbon atoms bearing R.sub.1 and R.sub.2 ;n is an integer of from 1 to 5;R.sub.3 is --COOH or --COOalkyl wherein the alkyl moiety has from 1 to 6 carbon atoms and is straight or branched;each of A and B is hydrogen or hydroxy with the proviso that at least one of A or B is hydrogen;or a pharmaceutically acceptable salt and individual isomers thereof.
    Type: Grant
    Filed: March 2, 1995
    Date of Patent: March 14, 2000
    Assignee: Hoechst Marion Roussel, Inc.
    Inventors: James K. Woodward, Richard A. Okerholm, Mark G. Eller, Bruce E. McNutt
  • Patent number: 5855912
    Abstract: The invention provides a pharmaceutical composition in solid unit dosage form, comprising, a) a therapeutically effective amount of a piperidinoalkanol compound or a pharmaceutically acceptable salt thereof; and, b) at least one inert ingredient.
    Type: Grant
    Filed: October 3, 1997
    Date of Patent: January 5, 1999
    Assignee: Hoechst Marion Roussel, Inc.
    Inventors: Thomas T. Ortyl, Paul F. Skultety, Kristen C. Mitchell, Deepak S. Phadke, Faraneh Attarchi, Marguerite L. Pierce, Aaron W. Schoeneman, Joseph M. Schnitz
  • Patent number: 5849866
    Abstract: This invention relates to analogs of peptidase substrates in which the amide group containing the scissile amide bond of the substrate peptide has been replaced by an activated electrophilic ketone moiety. These analogs of the peptidase substrates provide specific enzyme inhibitors for a variety of proteases, the inhibition of which will have useful physiological consequences in a variety of disease states.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: December 15, 1998
    Assignee: Merrell Pharmaceuticals Inc.
    Inventors: H. Michael Kolb, Joseph P. Burkhart, Michel J. Jung, Fritz E. Gerhart, deceased, Eugene L. Giroux, Bernhard Neises, Daniel G. Schirlin
  • Patent number: 5792841
    Abstract: This invention relates to certain novel 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivatives, and compositions thereof, which are useful in the treatment of patients afflicted with neoplastic or viral disease states.
    Type: Grant
    Filed: November 6, 1996
    Date of Patent: August 11, 1998
    Assignee: Merrell Pharmaceuticals Inc.
    Inventors: Michael L. Edwards, Donald P. Matthews
  • Patent number: 5753714
    Abstract: This invention relates to certain polyamine derivatives, to the methods and intermediates useful for their preparation, and to their use in treating diseases caused by infestation with a variety of parasitic protozoa.
    Type: Grant
    Filed: March 15, 1994
    Date of Patent: May 19, 1998
    Assignee: Merrell Pharmaceuticals Inc.
    Inventors: David M. Stemerick, Alan J. Bitonti, Michael L. Edwards, Peter P. McCann, Albert Sjoerdsma
  • Patent number: 5672724
    Abstract: The present invention relates to a novel method for preparing ranitidine and pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: November 16, 1995
    Date of Patent: September 30, 1997
    Assignee: Hoechst Marion Roussel, Inc.
    Inventor: Robert M. Strom
  • Patent number: 5654484
    Abstract: The present invention relates to a method for the treatment of patients suffering from certain neoplastic disease states which comprises administering a therapeutically effective amount of a compound of the formula: ##STR1## wherein m is an integer 6 to 9, Z is a saturated (C.sub.2 -C.sub.6) alkylene moiety, each R group independently is hydrogen, methyl, ethyl, or n-propyl except that both R groups cannot be hydrogen when Z is a straight chain; or a pharmaceutically acceptable acid addition salt thereof. Said treatment can optionally comprise conjunctive therapy with a polyamine oxidase inhibitor. The invention also relates to certain novel polyamine derivatives.
    Type: Grant
    Filed: June 1, 1995
    Date of Patent: August 5, 1997
    Assignee: Merrell Pharmaceuticals Inc.
    Inventors: Nellikunja J. Prakash, David M. Stemerick, Michael L. Edwards
  • Patent number: 5616702
    Abstract: This invention relates to certain novel 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivatives, and compositions thereof, which are useful in the treatment of patients afflicted with neoplastic or viral disease states.
    Type: Grant
    Filed: December 22, 1994
    Date of Patent: April 1, 1997
    Assignee: Merrell Pharmaceuticals Inc.
    Inventors: Michael L. Edwards, Donald P. Matthews, James R. McCarthy
  • Patent number: 5614557
    Abstract: .alpha.-Fluoromethyl- or .alpha.-difluoromethylornithine, and certain derivatives thereof, can be used alone or in combination with cytotoxic agents for the treatment of neoplastic diseases.
    Type: Grant
    Filed: March 14, 1995
    Date of Patent: March 25, 1997
    Assignee: Marion Merrell et Compagnie C/O Merrell Pharmaceuticals Inc.
    Inventors: Philippe Bey, Michel Jung
  • Patent number: 5607925
    Abstract: This invention relates to certain novel 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivatives, and compositions thereof, which are useful in the treatment of patients afflicted with neoplastic or viral disease states.
    Type: Grant
    Filed: November 1, 1994
    Date of Patent: March 4, 1997
    Assignee: Merrell Pharmaceuticals Inc.
    Inventors: Donald P. Matthews, Alan J. Bitonti, Michael L. Edwards, James R. McCarthy
  • Patent number: 5561152
    Abstract: The present invention provides novel aryloxy indanamines which are useful as anti-depressants and as inhibitors of synaptic norepinephrine and serotonin uptake.
    Type: Grant
    Filed: December 6, 1994
    Date of Patent: October 1, 1996
    Assignee: Merrell Pharmaceuticals Inc.
    Inventor: Jules Freedman
  • Patent number: 5532400
    Abstract: This invention relates to certain 2,6-di-alkyl-4-silyl-phenols which are useful as inhibitors of LDL lipid peroxidation and as antiatherosclerotic agents.
    Type: Grant
    Filed: December 12, 1994
    Date of Patent: July 2, 1996
    Assignee: Merrell Pharmaceuticals Inc.
    Inventors: Roger A. Parker, Simon J. T. Mao
  • Patent number: 5525633
    Abstract: The present invention relates to novel triaryl-ethylene derivatives that are useful as anti-neoplastic agents, antiatherosclerotic agents, and hypocholesterolemic agents.
    Type: Grant
    Filed: June 15, 1994
    Date of Patent: June 11, 1996
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Donald P. Matthews, Alan J. Bitonti, William A. Van Sickle, Donald A. Kaplan
  • Patent number: 5521162
    Abstract: This invention relates to certain aristeromycin/adenosine derivatives which are useful in inhibiting AdoMet-dependent transmethylation and in the treatment of patients afflicted with neoplastic or viral disease states.
    Type: Grant
    Filed: November 1, 1994
    Date of Patent: May 28, 1996
    Assignee: Merrell Pharmaceuticals Inc.
    Inventors: Esa T. Jarvi, James R. McCarthy, Nellikunja J. Prakash
  • Patent number: 5463181
    Abstract: The present invention relates to certain inhibitors of farnesyl:protein transferase which are useful as antineoplastic agents.
    Type: Grant
    Filed: November 8, 1993
    Date of Patent: October 31, 1995
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventor: David M. Stemerick
  • Patent number: 5436237
    Abstract: The present invention relates to 4-amino-.DELTA..sup.4 -steroids which are useful as inhibitors of 5.alpha.-reductase. The compounds are prepared by the reaction of an appropriate 4-azido steroid with triphenylphosphine in an aqueous inert solvent with heating.
    Type: Grant
    Filed: February 25, 1994
    Date of Patent: July 25, 1995
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Philip M. Weintraub, Joseph P. Burkhart, Thomas R. Blohm
  • Patent number: 5434145
    Abstract: The present invention relates to certain polyamine thiols which are useful as radioprotective agents.
    Type: Grant
    Filed: October 14, 1994
    Date of Patent: July 18, 1995
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Michael L. Edwards, Ronald D. Snyder
  • Patent number: 5378693
    Abstract: This invention relates to certain novel 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivatives, and compositions thereof, which are useful in the treatment of patients afflicted with neoplastic or viral disease states.
    Type: Grant
    Filed: August 27, 1993
    Date of Patent: January 3, 1995
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: James R. McCarthy, Michael L. Edwards, Donald P. Matthews
  • Patent number: 5318961
    Abstract: The present invention relates to 4-amino-.DELTA..sup.4 -steroids which are inhibitors of 5.alpha.-reductase. The compounds are useful for treating DHT-mediated diseases.
    Type: Grant
    Filed: December 20, 1992
    Date of Patent: June 7, 1994
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Philip M. Weintraub, Joseph P. Burkhart, Thomas R. Blohm
  • Patent number: 5308837
    Abstract: The present invention relates to a method of effecting immunosuppression in a patient in need thereof comprising administering to said patient an effective immunosuppressive amount of certain 5'-amine substituted adenosine analogs.
    Type: Grant
    Filed: November 12, 1992
    Date of Patent: May 3, 1994
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventor: Terry L. Bowlin